Chen Lung Tsai has served as Chairman of the Board since 2025 and has been a member of our board since 2014. Mr. Tsai also served as the Chairman of the Board for One Test Systems from 2018 to 2023; as USA Representative for TeraPower from 2016 to 2018; as Chief Operations Officer and board director for Lucis-Tech from 2015 to 2016; as President of Operations and Senior Vice President (“SVP”) of Manufacturing Operations for Greenliant Systems from 2010 to 2015; as SVP of Worldwide Backend Operations and a board director for Silicon Storage Technology from 1996 to 2010, as well as various other engineering roles in the semiconductor manufacturing industry. Mr. Tsai holds a B.S. from Show Chu University, and a M.S. in Physics and Electrical Engineering from the Florida Institute of Technology.
Julia Gouw has served as a member of our board of directors since 2025. Ms. Gouw has served as a board member and Chair of the Investment and Finance Committee for Pacific Life since 2011; and as Chair of the Board for Piermont Bank since 2019. Ms. Gouw also served as a board member and Chair of the Audit Committee for Vizio from 2021 to 2024; as the President and Chief Operating Officer of East West Bank from 2008 to 2016, Chief Financial Officer from 1994 to 2008, and Controller from 1989 to 1994; and as Senior Audit Manager at KPMG from 1983 to 1989. Ms. Gouw holds a B.S. in Accounting from the University of Illinois at Urbana-Champaign.
Michele Harari has served as a member of our board of directors since 2025. Ms. Harari currently owns and maintains a sustainable ranch where she oversees operations that include an AI-enabled agricultural venture. From 2016 to 2021, Ms. Harari served as the founder of Juju Life, an integrative therapies company; and prior to 2016, co-founded the Los Gatos School of Music. Ms. Harari attended Brandeis University where she obtained a B.A. in General Science and a minor in Creative Writing.
Joanne Imperial, M.D. has served as a member of our board of directors since 2025. Dr. Imperial has served as Chief Medical Officer at HepQuant LLC since March 2025 and as Director, Clinical Affairs since November 2024. Dr. Imperial also served as Senior Medical Director for Fortea from September 2020 to October 2024; as Vice President for Blade Therapeutics from February 2019 to September 2020; as Senior Medical Director for Conatus Pharmaceuticals from February 2017 to February 2019; as Medical Director for Fibrogen from August 2014 to February 2017; and as Medical Director, Medical Affairs for Onyx Pharmaceuticals from August 2010 to August 2014. Dr. Imperial also served in various academic and professorship roles at Stanford University from April 1995 to February 2017; and as Clinical Associate Professor at University of California, San Francisco from August 2007 to February 2010. Dr Imperial holds a B.S. in Psychology from Thomas Moore University and a M.D. from New York Medical College. Dr. Imperial completed her residency in medicine and fellowship in clinical nutrition/gastroenterology at New England Deaconess Hospital and also received her fellowship in gastroenterology from University of California, San Francisco.
Wen-Herng Henry King has served as a member of our board of directors since 2025. Mr. King has served as Chairman of Kashman Investment since 2015. Mr. King has also served as an independent director of Silergy Corp since 2019; as an independent director of Panram International since 2017; and as a director of Golden Bridge Electech since 2016. Mr. King has also served as an independent director of Chip Hope Ltd from 2015 to 2024; as Managing Director at Goldman Sachs Asia from 2006 to 2012; as well as various other finance roles in investment companies. Mr. King holds a B.S. in Electrical Engineering from National Central University in Taiwan and a M.B.A. from Loyola University of Chicago.
Hui Ying (Patty) Kuo has served as a member of our board of directors since 2024. Ms. Kuo has served as the Corporate Governance Officer for Asia Vital Components Co. since May 2020; as a Director for Furukawa Electric Co. since 2005; and as a Supervisor for Hongye Investment company since 2011. Ms. Kuo has also served as Director of Audit Operations for Asia Vital Components Co. from August 2008 to May 2020, and as its IPO Project Manager from 2001 to 2008; as Underwriting staff for Yuanta Securities Co. from 1996 to 2001; and as Audit Staff for PwC Taiwan, from 1992 to 1996. Ms. Kuo holds a B.S. in Accounting and a M.B.A. from Soochow University in Taiwan.
Kang-Huai (Johnny) Wang is a co-founder, a member of our board of directors, and has served as President and Chief Executive Officer since November 2024. Previously, he served as CapsoVision’s President and Chief Technology Officer from October 2006 to October 2024. Prior to joining the Company, Mr. Wang was Vice President of Engineering for ESS Technology, a technology company; Chief Executive Officer and co-founder of Divio, Inc, a video processing chip design company; and as Design Manager for C-Cube Mircrosystem, an IC design house. Mr. Wang has also held various engineering roles in the semiconductor industry. Mr. Wang holds a B.S. in electrical engineering from National Chiao-Tung University in Taiwan, and a M.S. in electrical engineering from Texas A&M University.